NO20014603D0 - Tienopyrimidinforbindelser, deres fremstilling og anvendelse - Google Patents

Tienopyrimidinforbindelser, deres fremstilling og anvendelse

Info

Publication number
NO20014603D0
NO20014603D0 NO20014603A NO20014603A NO20014603D0 NO 20014603 D0 NO20014603 D0 NO 20014603D0 NO 20014603 A NO20014603 A NO 20014603A NO 20014603 A NO20014603 A NO 20014603A NO 20014603 D0 NO20014603 D0 NO 20014603D0
Authority
NO
Norway
Prior art keywords
tienopyrimidine
compounds
preparation
tienopyrimidine compounds
Prior art date
Application number
NO20014603A
Other languages
English (en)
Other versions
NO20014603L (no
Inventor
Shuichi Furuya
Nobuhiro Suzuki
Nobuo Choh
Yoshi Nara
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20014603D0 publication Critical patent/NO20014603D0/no
Publication of NO20014603L publication Critical patent/NO20014603L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
NO20014603A 1999-03-24 2001-09-21 Tienopyrimidinforbindelser, deres fremstilling og anvendelse NO20014603L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7937199 1999-03-24
JP2000018019 2000-01-25
PCT/JP2000/001777 WO2000056739A1 (en) 1999-03-24 2000-03-23 Thienopyrimidine compounds, their production and use

Publications (2)

Publication Number Publication Date
NO20014603D0 true NO20014603D0 (no) 2001-09-21
NO20014603L NO20014603L (no) 2001-11-26

Family

ID=26420391

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014603A NO20014603L (no) 1999-03-24 2001-09-21 Tienopyrimidinforbindelser, deres fremstilling og anvendelse

Country Status (28)

Country Link
US (1) US6340686B1 (no)
EP (1) EP1163244B1 (no)
JP (1) JP3240293B2 (no)
KR (2) KR100533483B1 (no)
CN (1) CN1349536A (no)
AR (1) AR023152A1 (no)
AT (1) ATE261449T1 (no)
AU (1) AU764019B2 (no)
BR (1) BR0009297A (no)
CA (1) CA2368108C (no)
CZ (1) CZ294747B6 (no)
DE (1) DE60008862T2 (no)
DK (1) DK1163244T3 (no)
ES (1) ES2212992T3 (no)
HK (1) HK1042495B (no)
HU (1) HUP0200550A3 (no)
ID (1) ID30393A (no)
IL (1) IL145549A (no)
MX (1) MXPA01009566A (no)
MY (1) MY124726A (no)
NO (1) NO20014603L (no)
NZ (1) NZ514737A (no)
OA (1) OA11920A (no)
PL (1) PL351202A1 (no)
PT (1) PT1163244E (no)
SK (1) SK13552001A3 (no)
TW (1) TWI225863B (no)
WO (1) WO2000056739A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
KR20030005205A (ko) * 2000-02-29 2003-01-17 다케다 야쿠힌 고교 가부시키가이샤 티에노피리미딘 유도체의 제조 방법
EP1393747A1 (en) * 2000-04-13 2004-03-03 Takeda Chemical Industries, Ltd. Preventives/remedies for alzheimer's disease
CA2407472A1 (en) * 2000-06-14 2002-10-23 Takeda Chemical Industries, Ltd. Sustained release compositions
CA2423329A1 (en) * 2000-09-22 2003-03-20 Takeda Chemical Industries, Ltd. Solid preparations
WO2002043766A1 (fr) * 2000-11-29 2002-06-06 Takeda Chemical Industries, Ltd. Compositions medicinales et leur procede de preparation
WO2002047722A1 (fr) * 2000-12-15 2002-06-20 Takeda Chemical Industries, Ltd. Compositions medicinales agoniste ou antagoniste de la gonadoliberine non peptidyl, methode de production et utilisation desdites compositions
EP1374855A1 (en) * 2001-03-30 2004-01-02 Takeda Chemical Industries, Ltd. Medicinal solutions
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
JP2005505525A (ja) 2001-08-02 2005-02-24 ニューロクライン バイオサイエンシーズ， インコーポレイテッド 性腺刺激ホルモン放出ホルモンレセプターアンタゴニストおよびそれに関連する方法
WO2003011841A1 (en) 2001-08-02 2003-02-13 Neurocrine Biosciences, Inc. 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists
EP1411941A2 (en) 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
EP1412363A1 (en) 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists
WO2003064429A1 (fr) 2002-01-30 2003-08-07 Takeda Chemical Industries, Ltd. Thienopyrimidines, procedes de fabrication et d'utilisation correspondants
AU2003236039A1 (en) 2002-04-12 2003-10-27 Takeda Pharmaceutical Company Limited Preventives/remedies for hotflash
WO2004018479A1 (en) * 2002-08-21 2004-03-04 Astrazeneca Ab Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
CN101153042A (zh) 2003-01-29 2008-04-02 武田药品工业株式会社 噻吩并嘧啶化合物及其用途
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
US20060083017A1 (en) * 2004-10-18 2006-04-20 Bwt Propety, Inc. Solid-state lighting apparatus for navigational aids
US20090048273A1 (en) * 2005-07-22 2009-02-19 Takeda Pharmaceutical Company Limited Premature ovulation preventive agent
US20110172249A1 (en) 2008-09-03 2011-07-14 Takeda Pharmaceutical Company Limted Method for improving absorbability of preparation, and preparation having improved absorbability
JP6209171B2 (ja) * 2012-02-28 2017-10-04 ティウムバイオ カンパニー、リミテッドＴｉｕｍＢｉｏ Ｃｏ．， Ｌｔｄ． ゴナドトロピン放出ホルモン受容体アンタゴニスト、その製造方法および該アンタゴニストを含む医薬組成物
SI3415517T1 (sl) * 2012-09-28 2022-06-30 Takeda Pharmaceutical Company Limited Kristalna oblika 1-(4-1-(2,6-difluorobenzil)-5-dimetilaminometil-3-(6- metoksipiridazin-3-il)-2,4-diokso-1,2,3,4-tetrahidrotieno(2,3-D)- pirimidin-6il)fenil)-3-metoksiurea
FI3263110T3 (fi) 2015-02-26 2023-07-25 Takeda Pharmaceuticals Co Tabletti, joka käsittää metoksiureajohdannaista ja mannitolipartikkeleita
MX2019003733A (es) 2016-09-30 2019-09-26 Myovant Sciences Gmbh Tratamiento de cancer de prostata.
ES2912929T3 (es) 2016-09-30 2022-05-30 Myovant Sciences Gmbh Métodos de tratamiento de fibromas uterinos y endometriosis
KR101973074B1 (ko) * 2018-11-30 2019-04-26 주식회사 티움바이오 퓨로피리미딘 화합물의 염 및 결정형, 및 이를 포함하는 약학적 조성물
CN111943960B (zh) * 2019-07-29 2022-02-15 广东东阳光药业有限公司 取代的嘧啶二酮类化合物及其用途
CN111574534B (zh) * 2020-05-25 2021-06-04 东莞市东阳光新药研发有限公司 苯基取代的噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮类化合物及其用途
CN111909168B (zh) * 2020-07-31 2022-02-01 广东东阳光药业有限公司 含氮杂环基取代的嘧啶二酮类化合物及其用途
CN111925379B (zh) * 2020-07-31 2022-02-15 广东东阳光药业有限公司 含氮杂芳基取代的嘧啶二酮类化合物及其用途
CN112047957B (zh) * 2020-09-09 2022-02-01 广东东阳光药业有限公司 取代的嘧啶二酮类化合物及其用途
CN113754679B (zh) * 2020-09-09 2023-04-07 广东东阳光药业有限公司 取代的嘧啶二酮类化合物及其用途
CN113563303B (zh) * 2020-12-30 2022-04-12 上海博志研新药物技术有限公司 瑞卢戈利中间体及其制备方法
CN115260211B (zh) * 2021-04-29 2024-02-06 长春金赛药业有限责任公司 含噻吩稠环类衍生物、药物组合物及其制备方法和应用
CN113717149A (zh) * 2021-09-29 2021-11-30 成都伊诺达博医药科技有限公司 一种瑞卢戈利关键中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW449600B (en) * 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
UY23948A1 (es) * 1995-02-08 2001-10-25 Takeda Chemical Industries Ltd Derivados de anillos condensados de tiofeno su producción y uso.
US5627786A (en) * 1995-02-10 1997-05-06 Micron Quantum Devices, Inc. Parallel processing redundancy scheme for faster access times and lower die area
WO1996028405A1 (fr) * 1995-03-10 1996-09-19 Nitto Chemical Industry Co., Ltd. Procede de production de derives de 1,2-ethanediol

Also Published As

Publication number Publication date
ES2212992T3 (es) 2004-08-16
HUP0200550A3 (en) 2004-07-28
CZ20013419A3 (cs) 2002-02-13
PT1163244E (pt) 2004-07-30
EP1163244B1 (en) 2004-03-10
SK13552001A3 (sk) 2002-03-05
US6340686B1 (en) 2002-01-22
IL145549A (en) 2005-11-20
KR100370981B1 (ko) 2003-02-06
PL351202A1 (en) 2003-03-24
CN1349536A (zh) 2002-05-15
DE60008862D1 (de) 2004-04-15
DK1163244T3 (da) 2004-07-12
MXPA01009566A (es) 2002-05-14
WO2000056739A1 (en) 2000-09-28
ATE261449T1 (de) 2004-03-15
TWI225863B (en) 2005-01-01
CZ294747B6 (cs) 2005-03-16
AR023152A1 (es) 2002-09-04
CA2368108C (en) 2009-12-22
NO20014603L (no) 2001-11-26
KR20010015920A (ko) 2001-02-26
KR20010090430A (ko) 2001-10-18
HK1042495B (zh) 2004-10-08
NZ514737A (en) 2003-10-31
JP3240293B2 (ja) 2001-12-17
HK1042495A1 (en) 2002-08-16
HUP0200550A2 (en) 2002-06-29
AU764019B2 (en) 2003-08-07
MY124726A (en) 2006-06-30
EP1163244A1 (en) 2001-12-19
AU3326200A (en) 2000-10-09
BR0009297A (pt) 2001-12-18
IL145549A0 (en) 2002-06-30
JP2001278884A (ja) 2001-10-10
ID30393A (id) 2001-11-29
OA11920A (en) 2006-04-12
KR100533483B1 (ko) 2005-12-05
DE60008862T2 (de) 2005-01-27
CA2368108A1 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO20014603D0 (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO20021449L (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
NO20024742D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
NO20015113D0 (no) Nye forbindelser, deres fremstilling og anvendelse
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
NO20011956L (no) Substituerte fenylderivater, deres fremstilling og anvendelse
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO20005146D0 (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
NO20023146D0 (no) Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20020156D0 (no) Titanavledede forbindelser, fremstilling og anvendelse derav
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
NO20001782D0 (no) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO996156L (no) Substituerte cykloheptener, deres fremstilling og anvendelse
NO20012802D0 (no) Benzofuranderivater, deres fremstilling og anvendelse
NO20011921L (no) Sulfidoamidokarboksylsyre, deres fremstilling og anvendelse
DK1177196T3 (da) Heteroaryldiazabicycloalkaner, deres fremstilling og anvendelse